Literature DB >> 3780047

Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration.

P Gosset, L Prin, M Capron, C Auriault, A B Tonnel, A Capron.   

Abstract

Recent work has underlined a structural and metabolic heterogeneity amongst blood eosinophils in various hypereosinophilic diseases. Little is known about the factors responsible for this variability. We have identified granulocyte chemotactic factors, termed GCFs in the sera of five patients with hypereosinophilic syndrome (HES). Sera from normal controls or from 20 patients with blood hypereosinophilia of various causes, but with little or no hypodense blood eosinophils, did not demonstrate any chemotactic activity. Two distinct GCFs were characterized, either by gel filtration or isoelectric focusing (molecular weights of 600 kD and 240 kD; pIs of approximately 5 and 7). These fractions are sensitive to proteolytic enzymes and to heating to 100 degrees C but not to 56 degrees C. The activity of GCFs has been tested towards neutrophils and eosinophils. The fractions of 240 kD and pI 7 appear more selective for the eosinophil lineage. Checkerboard analysis shows that such fractions are primarily chemotactic. In addition, hypodense eosinophils appear defective in random motility and chemotaxis towards chemotactic agents which are effective on normodense eosinophils. Moreover, preincubation of normodense eosinophils with HES sera rendered these cells unresponsive to very efficient chemotactic agents such as leukotriene B4 (LTB4) (decrease in migration of 91%; P less than 10(-3), formyl methionyl leucyl phenylalanyl (Fmlp) (decrease of 95%; P less than 10(-2)), HES sera (decrease of 91 to 93%). These findings suggest a process of deactivation of blood eosinophils with the possible retention within the circulation of activated hypodense eosinophils in HES.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3780047      PMCID: PMC1542502     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  Eosinophil kinetics in two patients with eosinophilia.

Authors:  J C Herion; R M Glasser; R I Walker; J G Palmer
Journal:  Blood       Date:  1970-09       Impact factor: 22.113

3.  Pulmonary carcinoma with eosinophilia. Demonstration of a tumor-derived eosinophilopoietic factor.

Authors:  A Slungaard; J Ascensao; E Zanjani; H S Jacob
Journal:  N Engl J Med       Date:  1983-09-29       Impact factor: 91.245

4.  Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors.

Authors:  M A Vadas; N A Nicola; D Metcalf
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

Review 5.  The measurement of leucocyte chemotaxis.

Authors:  P C Wilkinson
Journal:  J Immunol Methods       Date:  1982-06-11       Impact factor: 2.303

6.  Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density.

Authors:  L Prin; J Charon; M Capron; P Gosset; H Taelman; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

7.  Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia.

Authors:  L Prin; M Capron; A B Tonnel; O Bletry; A Capron
Journal:  Int Arch Allergy Appl Immunol       Date:  1983

8.  Secretion of a chemotactic factor for neutrophils and eosinophils by alveolar macrophages from asthmatic patients.

Authors:  P Gosset; A B Tonnel; M Joseph; L Prin; A Mallart; J Charon; A Capron
Journal:  J Allergy Clin Immunol       Date:  1984-12       Impact factor: 10.793

9.  The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors:  S BOYDEN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

10.  Enhancement of human eosinophil-mediated killing of Schistosoma mansoni larvae by mononuclear cell products in vitro.

Authors:  M C Veith; A E Butterworth
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more
  2 in total

1.  Heterogeneity of human eosinophil glucocorticoid receptor expression in hypereosinophilic patients: absence of detectable receptor correlates with resistance to corticotherapy.

Authors:  L Prin; P Lefebvre; V Gruart; M Capron; L Storme; P Formstecher; S Loiseau; A Capron
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

2.  Presence of antibodies against endothelial cells in the sera of patients with episodic angioedema and hypereosinophilia.

Authors:  P Lassalle; P Gosset; V Gruart; L Prin; M Capron; G Lagrue; J P Kusnierz; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.